Monday, March 27, 2023
British Herald
Advertisement
  • Home
  • World
    • UK
    • Europe
    • Asia
    • Africa
    • Oceania
    • USA
    • Middle East
    • Latin America
  • Politics
  • Business
    • ECONOMY
    • Financial Markets
    • Companies
  • Sport
  • Fintech
  • Videos
  • Coffee Table Book
  • BH Magazine
  • More
    • Health
    • Entertainment
    • Science & Technology
    • Climate & Environment
    • Sustainability
    • Food and Travel
    • Fashion
    • Culture and Lifestyle
    • Articles
    • Opinion
No Result
View All Result
British Herald
  • Home
  • World
    • UK
    • Europe
    • Asia
    • Africa
    • Oceania
    • USA
    • Middle East
    • Latin America
  • Politics
  • Business
    • ECONOMY
    • Financial Markets
    • Companies
  • Sport
  • Fintech
  • Videos
  • Coffee Table Book
  • BH Magazine
  • More
    • Health
    • Entertainment
    • Science & Technology
    • Climate & Environment
    • Sustainability
    • Food and Travel
    • Fashion
    • Culture and Lifestyle
    • Articles
    • Opinion
No Result
View All Result
British Herald
Home Business

Novartis SMA treatment could get FDA approval in May

Editorial Bureau by Editorial Bureau
December 3, 2018
0
Novartis SMA treatment could get FDA approval in May

FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

ZURICH (Reuters) – Novartis’s <NOVN.S> gene therapy for spinal muscular atrophy (SMA) could be approved in May 2019 after the U.S. Food and Drug Administration agreed to an accelerated review of the Swiss drugmaker’s treatment.

You might also like

Alibaba founder Jack Ma has returned to China

SVB loans, deposits sold to First Citizens Bank

Gordon Moore, the titan of Silicon Valley, dies at 94

Novartis SMA treatment, now called Zolgensma, said on Monday it won FDA priority review after submitting clinical trial results for 15 patients, all of whom are alive at 24 months. The treatment may become one of the most-expensive one-time therapies ever, with Novartis pegging its value at $4-$5 million (£3.13-3.92 million) per patient.

(Reporting by John Miller)

Share30Tweet19
Editorial Bureau

Editorial Bureau

Recommended For You

Alibaba founder Jack Ma has returned to China

March 27, 2023
Jack Ma returns to China

Alibaba founder Jack Ma has returned to China, according to the South China Morning Post (SCMP). Capping a more than year-long overseas trip. Which industry observers saw as...

Read more

SVB loans, deposits sold to First Citizens Bank

March 27, 2023
SVB loans, deposits sold to First Citizens Bank

The Federal Deposit Insurance Corporation announced Monday that First Citizens Bank has decided to purchase Silicon Valley Bank's deposits and loans. The transaction involves $119 billion in deposits...

Read more

Gordon Moore, the titan of Silicon Valley, dies at 94

March 25, 2023
Gordon Moore, the titan of Silicon Valley

Gordon Moore, a pioneer in the microprocessor industry and a cofounder of Intel, which at one time was the world's largest semiconductor maker, died on Friday at the...

Read more

Fitch downgrades Argentina’s foreign currency rating to C

March 25, 2023
Argentina's foreign currency rating to C

Fitch credit rating agency downgrades Argentina's debt to one level above default. Argentina's foreign currency rating was downgraded to "C" from "CCC-" on Friday. Suggesting that the rating...

Read more

Scandal-plagued Japan tech giant Toshiba gets a tender offer

March 24, 2023
Toshiba Japan

Scandal-embattled Japanese electronics and technology manufacturer Toshiba has accepted a 2 trillion yen ($15 billion) tender offer from Japan Industrial Partners. A buyout fund made up of major...

Read more
No Result
View All Result
Who gonna buy out Manchester United? The frontrunners are ready to battle...

Who gonna buy out Manchester United? The frontrunners are ready to battle…

March 27, 2023
Capitol Police

Capitol Police seeking $840 million budget ahead of 2024

March 27, 2023
Prince Harry arrives at London court for privacy case

Prince Harry arrives unexpectedly at London court for privacy case

March 27, 2023

Tags

amazon australia boris johnson brexit britain British Herald CHINA Coronavirus coronavirus cases coronavirus outbreak COVID-19 COVID-19 Vaccine daily roundup Donald Trump Dubai expo 2020 england European Union facebook France germany Hong Kong india iran israel italy japan joe biden lockdown London new zealand north korea Rishi Sunak russia south korea spain T20 T20 World Cup taiwan thailand trending Trump turkey UK Ukraine usa
British Herald

Top News in World: Read Latest News on Sports, Business, Entertainment, Blogs and Opinions from leading columnists.

CATEGORIES

  • Africa
  • Articles
  • Asia
  • Brand Feature
  • Business
  • Climate & Environment
  • Companies
  • Crypto
  • Culture and Lifestyle
  • Daily Roundup
  • Economics
  • ECONOMY
  • edel
  • Entertainment
  • Europe
  • Fashion
  • Finance
  • Financial Markets
  • Fintech
  • Health
  • IN UK 01
  • IN UK 02
  • Investing
  • Latin America
  • Market
  • Middle East
  • nsp
  • Oceania
  • Opinion
  • Pharma/BioTech
  • Politics
  • Reviews
  • Science & Technology
  • Sport
  • Sustainability
  • Tech
  • Technology
  • Travel
  • UK
  • Uncategorized
  • USA
  • Videos
  • World

BROWSE BY TAGS

amazon australia boris johnson brexit britain British Herald CHINA Coronavirus coronavirus cases coronavirus outbreak COVID-19 COVID-19 Vaccine daily roundup Donald Trump Dubai expo 2020 england European Union facebook France germany Hong Kong india iran israel italy japan joe biden lockdown London new zealand north korea Rishi Sunak russia south korea spain T20 T20 World Cup taiwan thailand trending Trump turkey UK Ukraine usa

Herald Media Network Limited (UK). 2023. ALL RIGHTS RESERVED.

No Result
View All Result
  • Home
  • World
    • UK
    • Europe
    • Asia
    • Africa
    • Oceania
    • USA
    • Middle East
    • Latin America
  • Politics
  • Business
    • ECONOMY
    • Financial Markets
    • Companies
  • Sport
  • Fintech
  • Videos
  • Coffee Table Book
  • BH Magazine
  • More
    • Health
    • Entertainment
    • Science & Technology
    • Climate & Environment
    • Sustainability
    • Food and Travel
    • Fashion
    • Culture and Lifestyle
    • Articles
    • Opinion

Herald Media Network Limited (UK). 2023. ALL RIGHTS RESERVED.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?